Daihan Pharmaceutical Co.Ltd (023910) — Net Asset Quality Index
Daihan Pharmaceutical Co.Ltd (023910) has a Net Asset Quality Index of 85.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩344.02 Billion minus total liabilities of ₩50.75 Billion yields net assets of ₩293.27 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Daihan Pharmaceutical Co.Ltd's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Daihan Pharmaceutical Co.Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Daihan Pharmaceutical Co.Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 85.2%, representing net assets of ₩293.27 Billion against total assets of ₩344.02 Billion KRW. See Daihan Pharmaceutical Co.Ltd (023910) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Daihan Pharmaceutical Co.Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Daihan Pharmaceutical Co.Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Daihan Pharmaceutical Co.Ltd stock valuation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.1% | ₩275.99 Billion | ₩324.41 Billion | ₩48.42 Billion | ▲ +0.8 pp |
| 2023 | 84.3% | ₩247.97 Billion | ₩294.25 Billion | ₩46.28 Billion | ▲ +2.9 pp |
| 2022 | 81.4% | ₩225.40 Billion | ₩276.98 Billion | ₩51.58 Billion | ▲ +7.0 pp |
| 2021 | 74.4% | ₩202.81 Billion | ₩272.54 Billion | ₩69.73 Billion | ▲ +2.5 pp |
| 2020 | 71.9% | ₩181.92 Billion | ₩253.09 Billion | ₩71.17 Billion | ▲ +4.3 pp |
| 2019 | 67.6% | ₩166.78 Billion | ₩246.85 Billion | ₩80.08 Billion | ▲ +7.8 pp |
| 2018 | 59.8% | ₩140.36 Billion | ₩234.75 Billion | ₩94.39 Billion | ▼ -3.0 pp |
| 2017 | 62.8% | ₩115.88 Billion | ₩184.40 Billion | ₩68.52 Billion | ▲ +4.9 pp |
| 2016 | 58.0% | ₩92.94 Billion | ₩160.31 Billion | ₩67.36 Billion | ▲ +2.6 pp |
| 2015 | 55.3% | ₩76.84 Billion | ₩138.83 Billion | ₩61.99 Billion | ▲ +6.6 pp |
| 2014 | 48.7% | ₩64.10 Billion | ₩131.61 Billion | ₩67.52 Billion | — |